Alpine Global Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,302
Closed -$489K 261
2020
Q3
$489K Buy
+3,302
New +$511K 0.1% 113
2017
Q2
Sell
-5,358
Closed -$451K 250
2017
Q1
$451K Buy
+5,358
New +$429K 0.12% 154
2015
Q3
Sell
-8,016
Closed -$669K 492
2015
Q2
$669K Sell
8,016
-5,710
-42% -$435K 0.11% 140
2015
Q1
$997K Sell
13,726
-7,213
-34% -$514K 0.32% 67
2014
Q4
$1.45M Buy
+20,939
New +$1.41M 0.26% 94

Other funds holding LLY

Alpine Global Management's LLY Position: Q4 2020 in Review

Alpine Global Management sold out of Eli Lilly (LLY) in Q4 2020, closing a stake of 3,302 shares — an estimated $489K sold.

Alpine Global Management first reported a position in LLY in Q4 2014 and held it in 5 quarters. The position peaked at $1.45M in Q4 2014. 1,886 funds tracked by Wall St. Rank hold LLY as of Q4 2020.

  • Alpine Global Management reported no remaining Eli Lilly position as of Q4 2020 after selling out during the quarter.
  • Alpine Global Management sold 3,302 Eli Lilly shares in Q4 2020, an estimated $489K.
  • Alpine Global Management first reported a position in Eli Lilly in Q4 2014 and held it in 5 quarters.
  • Alpine Global Management's Eli Lilly position peaked at $1.45M in Q4 2014.
  • 1,886 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2020.

Based on Alpine Global Management's 13F filing for Q4 2020, filed 12 Feb 2021.